Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-09-19 Sale |
2022-09-21 8:01 pm |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
4,272 | $1.0697 | $4,570 | 39,061 (Direct) |
View |
2022-05-17 Purchase |
2022-05-19 7:43 pm |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
10,000 | $0.8228 | $8,228 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-03-01 Option Award |
2023-03-03 5:23 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
225,000 | $0 | 225,000 (Direct) |
View |
2022-09-14 Option Award(A) |
2022-09-21 7:55 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
33,333 | $0 | 43,333 (Direct) |
View |
2022-09-14 Option Award |
2022-09-16 7:26 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
25,000 | $0 | 35,000 (Direct) |
View |
2022-02-07 Option Award |
2022-02-09 5:10 pm |
N/A 2032-02-06 |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
485,000 | $0 | 485,000 (Direct) |
View |
Ownership |
2022-02-09 5:08 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |